These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2954723)

  • 21. Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure.
    Fifer MA; Molina CR; Quiroz AC; Giles TD; Herrmann HC; De Scheerder IR; Clement DL; Kubo S; Cody RJ; Cohn JN
    Am J Cardiol; 1990 Jan; 65(3):211-6. PubMed ID: 2136969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atrial natriuretic peptide as a preload depressor in acute renal failure secondary to congestive heart failure.
    Seta K; Hayashi T; Sugawara A; Kasuno K; Watanabe S; Sumi Y; Kijima Y; Kawaguchi K; Kotake C; Seo T; Toda T; Kuwahara T
    Ren Fail; 1998 Sep; 20(5):717-23. PubMed ID: 9768440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of a specific endothelin-converting enzyme inhibitor on cardiac, renal, and neurohumoral functions in congestive heart failure: comparison of effects with those of endothelin A receptor antagonism.
    Wada A; Tsutamoto T; Ohnishi M; Sawaki M; Fukai D; Maeda Y; Kinoshita M
    Circulation; 1999 Feb; 99(4):570-7. PubMed ID: 9927406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of continuous positive airway pressure on mitral regurgitant fraction and atrial natriuretic peptide in patients with heart failure.
    Tkacova R; Liu PP; Naughton MT; Bradley TD
    J Am Coll Cardiol; 1997 Sep; 30(3):739-45. PubMed ID: 9283534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natriuretic and antialdosterone actions of chronic oral NEP inhibition during progressive congestive heart failure.
    Martin FL; Stevens TL; Cataliotti A; Schirger JA; Borgeson DD; Redfield MM; Luchner A; Burnett JC
    Kidney Int; 2005 May; 67(5):1723-30. PubMed ID: 15840018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial natriuretic peptide release is more dependent on atrial filling volume than on filling pressure in chronic congestive heart failure.
    Globits S; Frank H; Pacher B; Huelsmann M; Ogris E; Pacher R
    Am Heart J; 1998 Apr; 135(4):592-7. PubMed ID: 9539472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diurnal change of plasma atrial natriuretic peptide concentrations in patients with congestive heart failure.
    Yoshino F; Sakuma N; Date T; Unoki T; Fukagawa K; Miyamoto T; Matsuda Y
    Am Heart J; 1989 Jun; 117(6):1316-9. PubMed ID: 2524954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of alpha-human atrial natriuretic polypeptide (alpha-hANP) on congestive heart failure in dogs].
    Sonoki H; Uchida Y; Masuo M; Tomaru T; Katoh A; Sugimoto T
    Nihon Yakurigaku Zasshi; 1987 Jan; 89(1):47-53. PubMed ID: 2952569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the levels of plasma atrial natriuretic peptide, hemodynamic measurements, and the levels of vasoactive hormones during the clinical course of congestive heart failure.
    Hara H; Ogihara T; Nakamaru M; Rakugi H; Tateyama H
    Clin Cardiol; 1988 Nov; 11(11):743-7. PubMed ID: 2976625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemodynamic, renal, and hormonal responses to alpha-human atrial natriuretic peptide in patients with congestive heart failure.
    Saito H; Ogihara T; Nakamaru M; Hara H; Higaki J; Rakugi H; Tateyama H; Minamino T; Iinuma K; Kumahara Y
    Clin Pharmacol Ther; 1987 Aug; 42(2):142-7. PubMed ID: 2955995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction.
    Tsutamoto T; Wada A; Maeda K; Hisanaga T; Maeda Y; Fukai D; Ohnishi M; Sugimoto Y; Kinoshita M
    Circulation; 1997 Jul; 96(2):509-16. PubMed ID: 9244219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
    van den Berg MP; Tjeerdsma G; Jan de Kam P; Boomsma F; Crijns HJ; van Veldhuisen DJ
    Eur J Heart Fail; 2002 Jun; 4(3):255-62. PubMed ID: 12034149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure.
    Elsner D; Muders F; Müntze A; Kromer EP; Forssmann WG; Riegger GA
    Am Heart J; 1995 Apr; 129(4):766-73. PubMed ID: 7900630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiorenal-endocrine dynamics during and following volume expansion.
    Zimmerman RS; Edwards BS; Schwab TR; Heublein DM; Burnett JC
    Am J Physiol; 1987 Feb; 252(2 Pt 2):R336-40. PubMed ID: 2949632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
    Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
    Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic oral endothelin type A receptor antagonism in experimental heart failure.
    Borgeson DD; Grantham JA; Williamson EE; Luchner A; Redfield MM; Opgenorth TJ; Burnett JC
    Hypertension; 1998 Mar; 31(3):766-70. PubMed ID: 9495259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
    La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
    Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute hemodynamic effects of alpha human atrial natriuretic polypeptide in patients with congestive heart failure.
    Serizawa T; Hirata Y; Kohmoto O; Iizuka M; Matsuoka H; Sato H; Takahashi T; Mochizuki T; Ishii M; Sugimoto T
    Jpn Heart J; 1988 Mar; 29(2):143-9. PubMed ID: 2969428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.